SCP: Lupin acquires Southern Cross Pharma in Australia
With the acquisition, Lupin's Generic Health subsidiary will gain access to over 60 registered products having sales of approximately $22 million.
Read full article »
Managing Director
Neill Stacey
SCP is an Australia-based company that researches and develops prescription medicinal products for retail pharmacy and healthcare sectors.
Read more